Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,782 | 1 | 58.3% |
| Food and Beverage | $1,276 | 17 | 41.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kaneka Medical America LLC | $1,782 | 1 | $0 (2023) |
| TerSera Therapeutics LLC | $1,081 | 14 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $80.51 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $78.58 | 1 | $0 (2021) |
| Intuitive Surgical, Inc. | $36.28 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $775.56 | 7 | TerSera Therapeutics LLC ($775.56) |
| 2023 | $2,068 | 7 | Kaneka Medical America LLC ($1,782) |
| 2022 | $19.69 | 1 | TerSera Therapeutics LLC ($19.69) |
| 2021 | $159.09 | 2 | Merck Sharp & Dohme Corporation ($80.51) |
| 2019 | $36.28 | 1 | Intuitive Surgical, Inc. ($36.28) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $120.27 | General |
| 10/30/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $152.28 | General |
| Category: Oncology | ||||||
| 10/29/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $192.91 | General |
| Category: Oncology | ||||||
| 10/17/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $44.63 | General |
| 10/04/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $137.56 | General |
| Category: Oncology | ||||||
| 06/12/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $91.00 | General |
| 04/16/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $36.91 | General |
| 12/04/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Oncology | ||||||
| 12/01/2023 | Kaneka Medical America LLC | — | Consulting Fee | Cash or cash equivalent | $1,782.01 | General |
| 11/30/2023 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $23.00 | General |
| 10/17/2023 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $34.95 | General |
| 09/05/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Oncology | ||||||
| 02/25/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $40.76 | General |
| Category: Oncology | ||||||
| 02/18/2023 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $160.72 | General |
| Category: Oncology | ||||||
| 12/13/2022 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Oncology | ||||||
| 12/03/2021 | Merck Sharp & Dohme Corporation | WELIREG (Drug) | Food and Beverage | In-kind items and services | $80.51 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $78.58 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $36.28 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 103 | 130 | $21,197 | $5,250 |
| 2021 | 11 | 346 | 443 | $99,018 | $30,501 |
| 2020 | 6 | 119 | 131 | $34,905 | $9,798 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 32 | $5,564 | $1,471 | 26.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 20 | $5,321 | $1,322 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 21 | $4,597 | $1,240 | 27.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 23 | 31 | $5,325 | $1,159 | 21.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 26 | $390.00 | $58.24 | 14.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $23,448 | $6,142 | 26.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 55 | $12,488 | $4,595 | 36.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 50 | 83 | $8,820 | $3,461 | 39.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 13 | 14 | $11,188 | $3,295 | 29.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 27 | 38 | $7,125 | $3,002 | 42.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 43 | 59 | $9,199 | $2,883 | 31.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $7,351 | $1,972 | 26.8% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 15 | 15 | $8,915 | $1,947 | 21.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 35 | 47 | $5,125 | $1,652 | 32.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 16 | $4,564 | $1,433 | 31.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 35 | 53 | $795.00 | $119.25 | 15.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 30 | 30 | $16,036 | $4,474 | 27.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 29 | 29 | $9,976 | $2,861 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 19 | $4,546 | $1,317 | 29.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $1,871 | $575.38 | 30.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 16 | $2,184 | $517.74 | 23.7% |
| 81003 | Automated urinalysis test | Office | 2020 | 20 | 24 | $292.00 | $54.00 | 18.5% |
About Dr. Nathan Wong, MD
Dr. Nathan Wong, MD is a Urology healthcare provider based in Hawthorne, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1548747215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Wong, MD has received a total of $3,058 in payments from pharmaceutical and medical device companies, with $775.56 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,782).
As a Medicare-enrolled provider, Wong has provided services to 568 Medicare beneficiaries, totaling 704 services with total Medicare billing of $45,550. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Hawthorne, NY
- Active Since 07/25/2018
- Last Updated 11/11/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548747215
Products in Payments
- Zoladex (Drug) $730.01
- WELIREG (Drug) $80.51
- XTANDI (Drug) $78.58
- Da Vinci Surgical System (Device) $36.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Hawthorne
Sean Fullerton, M.d, M.D
Urology — Payments: $3,254
Roger Riechers, Md, MD
Urology — Payments: $1,292
Dr. Andrew Katims, M.d., M.p.h, M.D., M.P.H
Urology — Payments: $1,206
Muhammad Choudhury, Md, MD
Urology — Payments: $392.17
Daniel Rosen, M.d, M.D
Urology — Payments: $386.23
Denton Allman, M.d, M.D
Urology — Payments: $339.59